Correspondence 0001213900-24-112749 from HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494) (HBIO)
HARVARD BIOSCIENCE INC (HBIO) (CIK 0001123494)
Date: Dec. 26, 2024 · CIK: 0001123494 · Accession: 0001213900-24-112749
AI Filing Summary & Sentiment
File numbers found in text: 333-283637
Letter
HARVARD BIOSCIENCE INC.
84 October Hill Road
Holliston, Massachusetts 01746-1371
December 26, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Margaret Sawicki
Re: Harvard Bioscience Inc.
Registration Statement on Form S-3
Filed December 6, 2024
File No. 333-283637
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Harvard Bioscience Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-283637) (the “Registration Statement”) be accelerated so that the Registration Statement will become effective on Friday, December 27, 2024 at 4:30 p.m. (Eastern Time), or as soon thereafter as practicable.
Please feel free to direct any questions or comments concerning this request to Daniel Woodard, Esq. of McDermott Will & Emery LLP at (212) 547-5553.
The Company understands that the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
HARVARD BIOSCIENCE INC.
By: /s/ James Green
Name: James Green
Title: Chief Executive Officer
cc: Daniel Woodard, McDermott Will & Emery LLP
Show Raw Text
CORRESP
1
filename1.htm
HARVARD BIOSCIENCE INC.
84 October Hill Road
Holliston, Massachusetts 01746-1371
December 26, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Margaret Sawicki
Re:
Harvard Bioscience Inc.
Registration Statement on Form S-3
Filed December 6, 2024
File No. 333-283637
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Harvard Bioscience Inc. (the “Company”) hereby requests that the effective
date of the Company’s Registration Statement on Form S-3 (File No. 333-283637) (the “Registration Statement”)
be accelerated so that the Registration Statement will become effective on Friday, December 27, 2024 at 4:30 p.m. (Eastern Time),
or as soon thereafter as practicable.
Please feel free to direct any
questions or comments concerning this request to Daniel Woodard, Esq. of McDermott Will & Emery LLP at (212) 547-5553.
The Company understands that
the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is
aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration
Statement.
HARVARD BIOSCIENCE INC.
By:
/s/ James Green
Name:
James Green
Title:
Chief Executive Officer
cc: Daniel Woodard, McDermott Will & Emery LLP